International Stem Cell Corp. (ISCO) Schedules Conference Call to Discuss Q1 2013 Financial Results
International Stem Cell Corp., a California-based biotechnology company developing novel stem cell based therapies, announced this morning that it will be hosting a conference call on Tuesday, May 14, 2013, to discuss its financial results for the three months ended March 31, 2013.
Dr. Simon Craw, Executive Vice President, and Mr. Jay Novak, Interim Chief Financial Officer, will be present. To participate in the call, please use the dial-in information below:
Date: Tuesday, May 14, 2013
Time: 11:00 a.m. Eastern Time
Conference Line (U.S.): 1-877-317-6776
International Dial-In: 1-412-317-6776
Conference ID: 10028807
Investors who wish to join the call should dial in at least 10 minutes prior to the starting time.
A playback of the call will be available until 11:00 a.m. ET on May 21. The recording can be heard following the call’s conclusion by calling 1-877-344-7529 within the United States or 1-412-317-0088 when calling internationally. Please use the replay pin number 10028807.
For more information on International Stem Cell Corp., visit www.intlstemcell.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com